Type 1 diabetes mellitus and risk of incident epilepsy:a population-based, open-cohort study by Dafoulas, George E et al.
 
 
University of Birmingham
Type 1 diabetes mellitus and risk of incident
epilepsy
Dafoulas, George E; Toulis, Konstantinos; Mccorry, Dougall; Kumarendran, Balachandran;
Thomas, G Neil; Willis, Brian H.; Gokhale, Krishna; Gkoutos, Georgios; Narendran, Parth;
Nirantharakumar, Krishnarajah
DOI:
10.1007/s00125-016-4142-x
License:
Creative Commons: Attribution (CC BY)
Document Version
Publisher's PDF, also known as Version of record
Citation for published version (Harvard):
Dafoulas, GE, Toulis, K, Mccorry, D, Kumarendran, B, Thomas, GN, Willis, BH, Gokhale, K, Gkoutos, G,
Narendran, P & Nirantharakumar, K 2017, 'Type 1 diabetes mellitus and risk of incident epilepsy: a population-
based, open-cohort study', Diabetologia, vol. 60, no. 2, pp. 258-261. https://doi.org/10.1007/s00125-016-4142-x
Link to publication on Research at Birmingham portal
Publisher Rights Statement:
Checked 04/11/2016
General rights
Unless a licence is specified above, all rights (including copyright and moral rights) in this document are retained by the authors and/or the
copyright holders. The express permission of the copyright holder must be obtained for any use of this material other than for purposes
permitted by law.
•	Users may freely distribute the URL that is used to identify this publication.
•	Users may download and/or print one copy of the publication from the University of Birmingham research portal for the purpose of private
study or non-commercial research.
•	User may use extracts from the document in line with the concept of ‘fair dealing’ under the Copyright, Designs and Patents Act 1988 (?)
•	Users may not further distribute the material nor use it for the purposes of commercial gain.
Where a licence is displayed above, please note the terms and conditions of the licence govern your use of this document.
When citing, please reference the published version.
Take down policy
While the University of Birmingham exercises care and attention in making items available there are rare occasions when an item has been
uploaded in error or has been deemed to be commercially or otherwise sensitive.
If you believe that this is the case for this document, please contact UBIRA@lists.bham.ac.uk providing details and we will remove access to
the work immediately and investigate.
Download date: 01. Mar. 2020
SHORT COMMUNICATION
Type 1 diabetes mellitus and risk of incident epilepsy:
a population-based, open-cohort study
George E. Dafoulas1,2 & Konstantinos A. Toulis1,3 & Dougall Mccorry4 &
Balachadran Kumarendran1 & G. Neil Thomas1 & Brian H. Willis1 & Krishna Gokhale1 &
George Gkoutos5 & Parth Narendran6,7 & Krishnarajah Nirantharakumar1,7
Received: 5 August 2016 /Accepted: 3 October 2016
# The Author(s) 2016. This article is published with open access at Springerlink.com
Abstract
Aims/Hypothesis The aim of this research was to explore the
relationship between incident epilepsy and type 1 diabetes in
British participants.
Methods Using The Health Improvement Network database,
we conducted a retrospective, open-cohort study. Patients
who were newly diagnosed with type 1 diabetes mellitus at
the age of ≤40 years were identified and followed-up from 1
January 1990 to 15 September 2015. These patients, identified
as not suffering from epilepsy at the time of diagnosis, were
randomly matched with up to four individuals without type 1
diabetes mellitus, based on age, sex and participating general
practice. A Cox regression analysis was subsequently per-
formed using Townsend deprivation index, cerebral palsy,
head injury and learning disabilities as model covariates.
Results The study population consisted of a total of 24,610
individuals (4922 with type 1 diabetes and 19,688 controls).
These individuals were followed up for a mean of 5.4 years
(approximately 132,000 person-years of follow up). Patients
with type 1 diabetes were significantly more likely to be diag-
nosed with epilepsy during the observation period compared
with controls (crude HR [95% CI]: 3.02 [1.95, 4.69]). The
incidence rate was estimated to be 132 and 44 per 100,000
person-years in patients and controls, respectively. This find-
ing persisted after adjusting for model covariates (adjusted HR
[95% CI]: 3.01 [1.93, 4.68]) and was also robust to sensitivity
analysis, excluding adult-onset type 1 diabetes mellitus.
Conclusions/Interpretation Patients with type 1 diabetes are
at approximately three-times greater risk of developing
epilepsy compared with matched controls without type 1
diabetes. This should be considered when investigating
seizure-related disorders in patients with type 1 diabetes
mellitus.
Keywords Epilepsy . Hypoglycaemia . Insulin . Seizures .
Type 1 diabetesmellitus
Introduction
Type 1 diabetes mellitus is characterised by the immune-
mediated destruction of pancreatic beta cells leading, ulti-
mately, to the loss of insulin production and lifelong depen-
dence on exogenous insulin. The disease affects over
370,000 adults in the UK, approximately 10% of the adult
diabetic population [1].
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Comorbidities associate with type 1 diabetes, either due to a
common etiopathogenesis (as in autoimmune polyglandular
syndromes) or due to metabolic (e.g. acute ketosis or chronic
vascular) and non-metabolic (e.g. depression) complications of
the disease. The potential association between type 1 diabetes
and neurological conditions, in particular epilepsy, has recently
received intense scrutiny [2–4]. Epidemiological evidence sug-
gests that the prevalence of type 1 diabetes in patients with idi-
opathic generalised epilepsies [5] and the prevalence of epilepsy-
related disorders in patients with type 1 diabetes may both be
increased [6]. Furthermore, a major acute metabolic complica-
tion of type 1 diabetes, diabetic ketoacidosis, was found to be
more frequent in patients with pre-existing epilepsy [7]. More
recently, a population-based study from Asia reported that the
risk of developing epilepsywas approximately three times higher
in patients with type 1 diabetes compared with controls [4].
On the other hand, the evidence outlined above has not been
universally replicated. A large study in the Australian popula-
tion reported no difference in the prevalence of epilepsy in type
1 diabetes [8]. However, the primary design of this study did
not address important variables, such as the potential distorting
effect of age (which was not controlled for in the study by Chou
et al [4]) and the possibility of a bidirectional relationship
between type 1 diabetes and epilepsy [9]. Furthermore, the
potential contribution of genetic background to the association
between type 1 diabetes and epilepsy warrants confirmation in
different populations. Finally, the relative rarity of the outcome
(epilepsy in patients with type 1 diabetes) and the possibility of
type I error inflation in the study by Chou et al [4], necessitates
the replication of these findings in a different cohort.
In this study, we aimed to explore the relationship between
epilepsy and type 1 diabetes in a large UK population. We
conducted a retrospective, open-cohort study using available
patient data residing in The Health Improvement Network
(THIN) database.
Methods
Selection of patients The study population (‘exposed patients’)
included all patients who were newly diagnosed with type 1
diabetes at the age of ≤40 years during the study period (study
start: 1 January 1990; study end: 15 September 2015).
Participants were selected based on the criteria of no diagnosis
of epilepsy at the time of diagnosis with type 1 diabetes.
Individuals were eligible for inclusion if they had been registered
with their general practice for ≥ 12 months. Patients with type 1
diabetes were followed up from the index date until the first of
the following events (exit date): (1) patient died; (2) patient left
health practice; (3) last data collection from health practice; (4)
patient diagnosed with epilepsy; (5) or patient reached 50 years
of age. The latter criterion was included since beyond this age
many other comorbidities may give rise to epilepsy.
A diagnosis of type 1 diabetes was defined as the presence
of a specific medical (Read) code indicating type 1 diabetes
and verified by the presence of treatment with insulin and the
absence of treatment with any oral glucose-lowering agent
other than metformin.
Selection of controls Individuals with type 1 diabetes were
randomly matched with up to four control individuals who
were registered at the same general practice. Control individ-
uals did not have a diagnosis of type 1 diabetes or epilepsy.
Age at index date (to within 1 year), sex and participating
general practice were use as matching variables.
Outcomes and covariates The primary outcome of the study
was the relative risk of incident diagnosis of epilepsy during
the observation period, expressed as HR. The accuracy of the
coding for epilepsy in the THIN database has been indepen-
dently verified in a previous study [10]. Covariates, selected
on the basis of biological plausibility, were used in the adjust-
ed analyses; covariates included Townsend deprivation index,
cerebral palsy, head injuries and learning disability. These
covariates were not matched.
Statistical analysis Baseline comparisons in continuous and
dichotomous/categorical characteristics were performed using
the Student’s t test and χ2 tests, respectively. A proportional
hazards model using Cox regression analysis was used for the
calculation of crude HR and adjusted HR, offset by the person-
years of exposure to determine whether the exposure to type 1
diabetes was associated with the risk of epilepsy. The propor-
tional hazards assumption (PHA) was tested before Cox regres-
sion analysis using Schoenfield and scaled Schoenfield resid-
uals. Point estimates of HRs were calculated with 95% CI and
the statistical significance threshold was set at 0.05. To explore
whether any association was different in adults and children, a
sensitivity analysis was performed limiting to patients with a
diagnosis of type 1 diabetes (and their respective controls) at the
age of 18 years or less. All analyses were performed using
Stata/MP (StataCorp, 2015, Stata Statistical Software: Release
14 [version 14.0], College Station, TX, USA). The study was
approved by the relevant Scientific Review Committee (SRC;
reference number 16THIN068).
Results
Cohort characteristics The study population consisted of a
total of 24,610 individuals (14,530 male and 10,080 fe-
male). The patients (4922 exposed to type 1 diabetes and
19,688 controls) were followed up for a mean of 5.4 years
(totalling approximately 132,000 person-years of follow
up). The mean age of each cohort was 17.9 years
(Table 1). In total, 81 incident cases of epilepsy were
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recorded during the observation period (Table 2). A diag-
nosis of learning disability and cerebral palsy were re-
corded in 85 individuals (0.3% of the total population)
and 27 individuals (0.1% of the total population), respec-
tively. Approximately 8.6% of the total population
(n= 2125) had a previous diagnosis of head injury, includ-
ing skull fractures. Table 1 provides a summary of the key
study characteristics.
Risk of incident epilepsy Patients with type 1 diabetes were
significantly more likely to be diagnosed with epilepsy during
the observation period compared with controls (crude HR
[95%CI]: 3.02 [1.95, 4.69]; p<0.001; Table 2). The incidence
rate was estimated at 132 and 44 per 100,000 person-years in
type 1 diabetic patients and controls, respectively. This finding
remained robust after adjusting for key covariates (adjusted
HR [95% CI]: 3.01 [1.93, 4.68], Table 2).
Sensitivity analysis In patients diagnosed with type 1
diabetes at the age of 18 years or less, the risk of
developing epilepsy during the observation period was
significantly higher compared with controls (crude HR
[95% CI]: 3.44 [1.99, 5.96], Table 2). Again, these find-
ings remained unchanged following adjustments for key
covariates (adjusted HR [95% CI]: 3.40 [1.97, 5.88],
Table 2).
Discussion
In this population-based, open cohort study, patients with type
1 diabetes were found to be at approximately three-times
greater risk of developing epilepsy than matched controls
without type 1 diabetes. This increase in the risk of epilepsy
was robust to sensitivity analyses, including subgroups of
adolescent patients with type 1 diabetes.
Table 1 Baseline characteristics
of the study population Characteristics Exposed to type 1 diabetes Control p value
n= 4922 n= 19,688
Age, years 17.9 (10.7) 17.9 (10.7) 0.97
Male, n (%) 2906 (59.0) 11,624 (59.0) 0.99
Follow up, years 5.38 (4.0) 5.36 (4.0) 0.75
Townsend deprivation index, n (%) 0.49b
1 1080 (22.0) 4429 (22.5)
2 949 (19.3) 3814 (19.4)
3 1027 (20.9) 3932 (20.0)
4 874 (17.8) 3645 (18.5)
5 723 (14.7) 2772 (14.1)
NA 269 (5.5) 1096 (5.6)
Cerebral palsy, n (%) 3 (0.1) 24 (0.1) 0.28
Head injurya, n (%) 424 (8.6) 1701 (8.6) 0.95
Learning disability, n (%) 24 (0.5) 61 (0.3) 0.06
Data are presented as mean (SD) or n (%).
a Includes skull fracture
b p value derived from categorical Townsend deprivation index data in the exposed vs control cohorts
NA, not available
p values are derived from Student’s t tests or χ2 test
Table 2 Risk of epilepsy in pa-
tients with type 1 diabetes
mellitus in UK
Variable Exposed to type
1 diabetes
Controls Exposed to type 1 diabetes
at ≤18 years of agea
Controlsa
n 4922 19,688 2893 11,550
Person-years, years 26,499 105,598 16,015 62,525
Incident diagnosis of epilepsy, n 35 46 24 28
Incidence rate (per 100,000
person-years), n
132 44 150 45
Mean follow up, years 5.52 5.42 5.54 5.41
Unadjusted HR (95% CI) 3.02 (1.95, 4.69)*** 3.44 (1.99, 5.96)***
Adjusted HR (95% CI)b 3.01 (1.93, 4.68)*** 3.40 (1.97, 5.88)***
a Limited to individuals with onset of type 1 diabetes at ≤18 years of age and age-matched controls
b Adjusted for social deprivation, cerebral palsy, head injury and learning disability
***p< 0.001, individuals with type 1 diabetes vs controls
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The validity this study confers to the literature is important in
several aspects. First, this study included the largest cohort of
patients with newly diagnosed type 1 diabetes (n=4922 patients)
to date. Furthermore, the temporal sequence (diagnosis of type 1
diabetes followed by a diagnosis of epilepsy) was ascertained by
a reproducible, computerised procedure. Importantly, key poten-
tial modifiers of the outcomes, such as age [9], learning disabil-
ities and related comorbidities were taken into account in the
analysis, either as a matching variable (age) or as model covar-
iates. Finally, appropriate sensitivity analyses were undertaken to
explore whether any relationship identified was age dependent
(adult vs adolescent type 1 diabetes).
The findings of the present study are directly comparable
with the recent report by Chou et al that explored the association
of type 1 diabetes with incident epilepsy in an Asian population
[4]. Compared with our study, there is a potential for differences
in ethnic and genetic backgrounds of participants, a notable
disparity in the epilepsy incidence rate (whichwas approximate-
ly three times greater in the Asian cohort compared with our
study), and differences in study size and analysis (age was not
used as amatching variable and there were fewer type 1 diabetic
patients in the Asian cohort). Nonetheless, the findings from the
research by Chou et al were practically identical to those in the
present study [4]. The consistently reported three-time greater
risk of incident epilepsy in type 1 diabetes patients, indepen-
dently validated in, at least, the cohort in the present study and
that in the study by Chou et al, suggests a finding of relevance
rather than artefact. On the other hand, it should be noted that
patients with type 1 diabetes are closely monitored in the
healthcare system and this might, in itself, increase the chance
of being diagnosed with other conditions, such as epilepsy.
The mechanism of association between type 1 diabetes and
epilepsy remains unclear. It may relate to shared genetic or
shared autoimmune factors [9, 11, 12], or the result of cerebro-
vascular damage resulting from metabolic abnormalities [13].
Clarification of the underlying mechanism would possibly facil-
itate the recognition of those at risk, help to manage and reduce
this risk, as well as accelerate necessary changes in patient care.
Whilst the association between type 1 diabetes mellitus and
epilepsy would ideally be validated in a prospective setting,
the results of our study suggest that it is advisable for
healthcare professionals to seriously consider epilepsy, along-
side hypoglycaemia, in the differential diagnosis of seizure-
related disorders in patients with type 1 diabetes.
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